General Information of Drug Off-Target (DOT) (ID: OT3O4INM)

DOT Name Integrator complex subunit 15 (INTS15)
Gene Name INTS15
UniProt ID
INT15_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF14964
Sequence
MSDIRHSLLRRDALSAAKEVLYHLDIYFSSQLQSAPLPIVDKGPVELLEEFVFQVPKERS
AQPKRLNSLQELQLLEIMCNYFQEQTKDSVRQIIFSSLFSPQGNKADDSRMSLLGKLVSM
AVAVCRIPVLECAASWLQRTPVVYCVRLAKALVDDYCCLVPGSIQTLKQIFSASPRFCCQ
FITSVTALYDLSSDDLIPPMDLLEMIVTWIFEDPRLILITFLNTPIAANLPIGFLELTPL
VGLIRWCVKAPLAYKRKKKPPLSNGHVSNKVTKDPGVGMDRDSHLLYSKLHLSVLQVLMT
LQLHLTEKNLYGRLGLILFDHMVPLVEEINRLADELNPLNASQEIELSLDRLAQALQVAM
ASGALLCTRDDLRTLCSRLPHNNLLQLVISGPVQQSPHAALPPGFYPHIHTPPLGYGAVP
AHPAAHPALPTHPGHTFISGVTFPFRPIR
Function Probable component of the Integrator (INT) complex, a complex involved in the small nuclear RNAs (snRNA) U1 and U2 transcription and in their 3'-box-dependent processing.

Molecular Interaction Atlas (MIA) of This DOT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
12 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Tretinoin DM49DUI Approved Tretinoin decreases the expression of Integrator complex subunit 15 (INTS15). [1]
Cisplatin DMRHGI9 Approved Cisplatin decreases the expression of Integrator complex subunit 15 (INTS15). [2]
Temozolomide DMKECZD Approved Temozolomide increases the expression of Integrator complex subunit 15 (INTS15). [3]
Selenium DM25CGV Approved Selenium increases the expression of Integrator complex subunit 15 (INTS15). [4]
Etoposide DMNH3PG Approved Etoposide decreases the expression of Integrator complex subunit 15 (INTS15). [2]
Mitomycin DMH0ZJE Approved Mitomycin decreases the expression of Integrator complex subunit 15 (INTS15). [2]
Colchicine DM2POTE Approved Colchicine decreases the expression of Integrator complex subunit 15 (INTS15). [2]
Hydroxyurea DMOQVU9 Approved Hydroxyurea decreases the expression of Integrator complex subunit 15 (INTS15). [2]
Adenine DMZLHKJ Approved Adenine decreases the expression of Integrator complex subunit 15 (INTS15). [2]
Urethane DM7NSI0 Phase 4 Urethane increases the expression of Integrator complex subunit 15 (INTS15). [5]
Tocopherol DMBIJZ6 Phase 2 Tocopherol increases the expression of Integrator complex subunit 15 (INTS15). [4]
PMID28460551-Compound-2 DM4DOUB Patented PMID28460551-Compound-2 increases the expression of Integrator complex subunit 15 (INTS15). [6]
------------------------------------------------------------------------------------
⏷ Show the Full List of 12 Drug(s)

References

1 Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. Cells. 2020 Nov 5;9(11):2423. doi: 10.3390/cells9112423.
2 Utilization of CDKN1A/p21 gene for class discrimination of DNA damage-induced clastogenicity. Toxicology. 2014 Jan 6;315:8-16. doi: 10.1016/j.tox.2013.10.009. Epub 2013 Nov 6.
3 Temozolomide induces activation of Wnt/-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy. Cell Biol Toxicol. 2020 Jun;36(3):273-278. doi: 10.1007/s10565-019-09502-7. Epub 2019 Nov 22.
4 Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer. J Natl Cancer Inst. 2009 Mar 4;101(5):306-20.
5 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
6 Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761. doi: 10.1016/j.taap.2019.114761. Epub 2019 Sep 15.